Graded coronavirus disease 2019 vaccine administration: A safe alternative to vaccine avoidance

Mitchell M. Pitlick, Alexei Gonzalez-Estrada, Miguel A. Park

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Journal	Annals of Allergy, Asthma and Immunology
DOIs	https://doi.org/10.1016/j.anai.2022.02.024
State	Accepted/In press - 2022

ASJC Scopus subject areas

@article{3ff4e56e90894e75acb59cbf9b1cfde0,

title = "Graded coronavirus disease 2019 vaccine administration: A safe alternative to vaccine avoidance",

author = "Pitlick, {Mitchell M.} and Alexei Gonzalez-Estrada and Park, {Miguel A.}",

note = "Funding Information: Funding: The authors have no funding sources to report.",

year = "2022",

doi = "10.1016/j.anai.2022.02.024",

language = "English (US)",

journal = "Annals of Allergy, Asthma and Immunology",

issn = "1081-1206",

publisher = "American College of Allergy, Asthma and Immunology",

}

TY - JOUR

T1 - Graded coronavirus disease 2019 vaccine administration

T2 - A safe alternative to vaccine avoidance

AU - Pitlick, Mitchell M.

AU - Gonzalez-Estrada, Alexei

AU - Park, Miguel A.

N1 - Funding Information: Funding: The authors have no funding sources to report.

PY - 2022

Y1 - 2022

UR - http://www.scopus.com/inward/record.url?scp=85127307789&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85127307789&partnerID=8YFLogxK

U2 - 10.1016/j.anai.2022.02.024

DO - 10.1016/j.anai.2022.02.024

M3 - Article

C2 - 35257875

AN - SCOPUS:85127307789

JO - Annals of Allergy, Asthma and Immunology

JF - Annals of Allergy, Asthma and Immunology

SN - 1081-1206

ER -